0310-0625 : Koselugo 25 mg Oral Capsule
| NDC: | 0310-0625 |
| Labeler: | Astrazeneca Pharmaceuticals Lp |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Koselugo |
| Dosage Form: | Oral Capsule |
| Application #: | NDA213756 |
| Rev. Date: |
Appearance:
| Markings: | SEL;25 |
| Shapes: |
Capsule |
| Colors: |
 Blue |
| Size (mm): | 14 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0310-0625-28: 28 CAPSULE IN 1 BOTTLE (0310‑0625‑28)
- 0310-0625-60: 60 CAPSULE IN 1 BOTTLE (0310‑0625‑60)
Active Ingredients:
- Selumetinib
Dosage Strength:
- 25 mg
Inactive Ingredients:
- Tocophersolan
- Hypromellose, Unspecified
- Carrageenan
- Potassium Chloride
- Fd&c Blue No. 2
- Ferric Oxide Yellow
- Titanium Dioxide
- Ferric Oxide Red
- Carnauba Wax
- Shellac
- 1-butanol, 4-(ethenyloxy)-
- Alcohol
- Water
- Glyceryl Oleate /
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]
- Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0310-0610 Koselugo 10 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0310-0610Next: 0310-0657 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.